Showing results (241-250 of 302) with videos related to
Sort By:
Pageof 31
American Journal of Hematology|March 20, 2024
Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B-cell lymphoma after 2 or more lines of prior therapyMatthew A Lunning, Hai-Lin Wang, Zhen-Huan Hu, et al.Cancer|April 16, 2026
Assessing patient perspectives on enrollment in lymphoma clinical trialsNeha Akkad, Minxing Chen, Sophia Nguyen, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 29, 2018
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector CellsDaniel W Lee, Bianca D Santomasso, Frederick L Locke, et al.Clinical and Translational Radiation Oncology|May 23, 2022
Second malignancies in patients with Hodgkin's Lymphoma: Half a century of experienceBouthaina Shbib Dabaja, David Boyce-Fappiano, Wenli Dong, et al.Blood Cancer Journal|August 28, 2020
Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different featuresWen Shuai, Pei Lin, Paolo Strati, et al.The Lancet. Haematology|July 3, 2025
Off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy in relapsed or refractory B-cell lymphoma: a multicentre, open-label, phase 1 studyPaolo Strati, Januario Castro, Aaron Goodman, et al.Nature Medicine|March 14, 2023
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapyChristoph K Stein-Thoeringer, Neeraj Y Saini, Eli Zamir, et al.Blood|October 23, 2024
Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapyRishika Prasad, Abdur Rehman, Lubna Rehman, et al.Science Signaling|February 18, 2016
ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignanciesJo Ishizawa, Kensuke Kojima, Dhruv Chachad, et al.British Journal of Haematology|June 20, 2014
Double hit lymphoma: the MD Anderson Cancer Center clinical experienceYasuhiro Oki, Mansoor Noorani, Pei Lin, et al.Pageof 31